Reforming and Modernizing the NRC's Radiation Protection Framework
The U.S. Nuclear Regulatory Commission (NRC) is proposing to amend its regulations that govern its standards for protection against radiation. These proposed revisions would address section 5(b) of Executive Order 14300, "Ordering the Reform of the Nuclear Regulatory Commission," and would reflect the NRC's experience and other developments in the field of radiation protection since the NRC's last major revisions to these standards in 1991. In addition, the NRC is issuing for public comment draft implementing guidance.
Read the official notice →Source: Federal Register (FDA/USDA food labeling) · US Government work (public domain). This is a short, attributed summary; the full authoritative text lives on the authority’s own site. LabelYog does not author or endorse it — confirm compliance against the destination market’s official source.
More from United States
- Self-Regulatory Organizations; Cboe Exchange, Inc.; Notice of Filing of a Proposed Rule Change To Amend its Rules To Permit the Listing of Binary Options Overlying Key Performance Indicators (“KPIs”) Reported by Certain Issuers of Stock (“Binary KPI Options”) regulatory
- Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs regulatory
- Bacteriophage Active Against Xanthomonas campestris pv. vesicatoria_EcoPhage and Bacteriophage Active Against Pseudomonas syringae pv. tomato_EcoPhage; Exemptions from the Requirement of a Pesticide Tolerance regulatory
- Amendments and Nonconformance Penalties for Model Year 2027 and Later Heavy-Duty Highway Engines and Amendments to Inducement Provisions for SCR-Equipped Diesel Engines regulatory
- Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments regulatory
- Schedules of Controlled Substances: Placement of Tianeptine in Schedule I regulatory
What this means for your label
A notice like this changes what a pack must carry. These are the rules we build against, starting with US FDA.